For more than a century, the tablet has been the default way to take medicine. It's cheap, familiar and easy to manufacture. But for a surprising number of people, swallowing a pill is the single hardest part of their treatment — and that friction quietly undermines whether a product works at all.
An estimated one in three adults struggles to swallow tablets and capsules. For children, older adults, and anyone on the move without water, that difficulty turns a simple dose into a daily obstacle. When taking the medicine is unpleasant, people skip doses — and adherence, not the molecule, becomes the thing that decides the outcome.
This is exactly the gap oral disintegrating films (ODFs) are built to close.
What is an oral disintegrating film?
An ODF is an ultra-thin strip — thinner than a postage stamp — that carries a precise dose of an active ingredient. Placed on the tongue, it disintegrates in seconds, with no water and no swallowing a tablet or chewing a gummy. Because it dissolves against the moist lining of the mouth, part of the dose can be absorbed directly across the oral mucosa, rather than travelling the full length of the digestive tract first.
The result is a format that feels effortless to the person taking it, and opens up new possibilities for the brand behind it.
Why brands are switching to films
The appeal of ODFs isn't only about comfort. For the companies making them, films solve several problems at once:
- Better adherence. A dose that's genuinely pleasant to take is a dose people actually take — every day, as prescribed.
- Faster onset. Buccal absorption can bypass part of first-pass metabolism, supporting a quicker, more efficient effect.
- Real differentiation. In a crowded shelf of tablets, capsules and gummies, a film is an instantly modern, premium format that stands apart.
- Clean-label freedom. Films can be formulated sugar-free, vegan and free from common allergens, with natural flavours and colours.
- Precision. Every strip carries an accurate, reproducible dose — batch after batch.
"The hardest part of a medicine shouldn't be taking it. Films remove that friction — and that changes whether a product succeeds."
The real challenge is formulation
Making a film that looks good is easy. Making one that carries a difficult active, masks a bitter taste, dissolves at exactly the right rate, stays stable on the shelf, and delivers a consistent dose — that's where the science lives.
Actives are often bitter, moisture-sensitive or poorly soluble. Getting them into a thin film without compromising taste, stability or dose accuracy takes deep formulation know-how and techniques like taste-masking, microencapsulation and liposomal delivery. This is where an experienced platform earns its place: it reduces development risk and gets a viable formulation to the finish line faster.
From molecule to market — under one roof
A great formulation still has to become a real, shelf-ready product. That journey spans concept and custom formulation, development and R&D, automated manufacturing, in-house quality control, and moisture-protected, serialised packaging for regulated markets. When those stages sit with a single accountable partner rather than a chain of vendors, timelines shrink and quality stays consistent from the first lab batch to the last commercial dose.
Who ODFs are for
Films aren't a niche. They fit prescription medicines where adherence matters, nutraceuticals and supplements that want a modern, clean-label edge, and any audience — paediatric, geriatric, travel — where swallowing a tablet is a barrier. If it can be dosed, there's a good chance it can be filmed.
The tablet won't disappear. But for a growing number of molecules and brands, the question is no longer "can we make this easier to take?" — it's "why haven't we already?"